Effectiveness of Different COVID-19 Vaccines in the United Arab Emirates: A Retrospective Cross-sectional Study

Background: The COVID-19 virus continues to represent a threat to global healthcare systems. The novel strains, such as Delta and Omicron, possibly further increase transmission concerns. Despite widespread vaccine availability in the United Arab Emirates (UAE), vaccine hesitancy exists due to safety concerns, misinformation, and socioeconomic issues. We, in this study, aim to analyze the factors that could influence COVID-19 vaccination status and compare the efficacy of existing vaccines (Pfizer, Sinopharm, and AstraZeneca) in preventing hospitalization. Methods: We conducted a cross-sectional retrospective study at the Al Towar Primary Health Centre in Dubai, UAE, from March to December 2022. We obtained demographics, comorbidities, BMI, vaccination status, and hospitalization outcomes from Dubai Health Authority (DHA) electronic health records (Epic/SALAMA, Nabidh) and supplemented with structured phone interviews. Vaccinated individuals got at least one dose of any UAE-approved vaccination. We conducted the analysis with Jamovi software (version 2.3.28), employing Pearson's chi-square and Fisher's exact tests. Results: Out of the 500 patients we included, 446 were vaccinated and 54 were unvaccinated. The unvaccinated group had considerably more females (76.6% vs. 53.5%, p < 0.01), as well as higher rates of morbid obesity and chronic kidney disease. Individuals who had not been vaccinated had approximately three times the rate of hospitalization (10.6% vs. 3.6%, p = 0.054). No significant difference in hospitalization was seen for vaccination various types (Pfizer, Sinopharm, and AstraZeneca). Conclusion: Vaccination considerably reduces severe COVID-19 outcomes, while unvaccinated people are more likely to be hospitalized. Our findings are consistent with global evidence of vaccine efficacy, and future measures should address sociocultural barriers, target high-risk groups, and challenge disinformation to increase adoption.

Authors

Publication Details

Journal
Microbiology & Infectious Diseases
Published
2025-08-31
DOI
https://doi.org/10.33425/2639-9458.1218
Primary Topic
Diverse Scientific Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effectiveness of Different COVID-19 Vaccines in the United Arab Emirates: A Retrospective Cross-sectional Study

Dina Siddiq Abdulhadi Alajmani, Abdalla Alzaabi, Adil Maqbool, Ahmed Alhammadi et al.
Microbiology & Infectious Diseases
Diverse Scientific Research Studies
article

Effectiveness of Different COVID-19 Vaccines in the United Arab Emirates: A Retrospective Cross-sectional Study

Dina Siddiq Abdulhadi Alajmani, Abdalla Alzaabi, Adil Maqbool, Ahmed Alhammadi, Elham Ahmed, Farzaneh Mohammad Abedini, Leila Osman Koshin, Haider Gaib Taleb, Faiza Rasheedudheen
article en

Abstract

Background: The COVID-19 virus continues to represent a threat to global healthcare systems. The novel strains, such as Delta and Omicron, possibly further increase transmission concerns. Despite widespread vaccine availability in the United Arab Emirates (UAE), vaccine hesitancy exists due to safety concerns, misinformation, and socioeconomic issues. We, in this study, aim to analyze the factors that could influence COVID-19 vaccination status and compare the efficacy of existing vaccines (Pfizer, Sinopharm, and AstraZeneca) in preventing hospitalization. Methods: We conducted a cross-sectional retrospective study at the Al Towar Primary Health Centre in Dubai, UAE, from March to December 2022. We obtained demographics, comorbidities, BMI, vaccination status, and hospitalization outcomes from Dubai Health Authority (DHA) electronic health records (Epic/SALAMA, Nabidh) and supplemented with structured phone interviews. Vaccinated individuals got at least one dose of any UAE-approved vaccination. We conducted the analysis with Jamovi software (version 2.3.28), employing Pearson's chi-square and Fisher's exact tests. Results: Out of the 500 patients we included, 446 were vaccinated and 54 were unvaccinated. The unvaccinated group had considerably more females (76.6% vs. 53.5%, p < 0.01), as well as higher rates of morbid obesity and chronic kidney disease. Individuals who had not been vaccinated had approximately three times the rate of hospitalization (10.6% vs. 3.6%, p = 0.054). No significant difference in hospitalization was seen for vaccination various types (Pfizer, Sinopharm, and AstraZeneca). Conclusion: Vaccination considerably reduces severe COVID-19 outcomes, while unvaccinated people are more likely to be hospitalized. Our findings are consistent with global evidence of vaccine efficacy, and future measures should address sociocultural barriers, target high-risk groups, and challenge disinformation to increase adoption.

Microbiology & Infectious DiseasesVol. 9(4)
Openalex Percentile: Top 62%
Diverse Scientific Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.